Webinar: A Comparison of cfDNA Approaches to Guide Targeted Therapy in NSCLC More
Webinar: Going beyond EGFR - Evaluating Technologies for Molecular Genetic Testing in NSCLC More
Webinar: Targeted Detection of MET and NTRK Oncogenic Variants in Routine Molecular Analysis More
Webinar: Validating a Diagnostic Mass Spec Platform for a Molecular Pathology Service Lab More
Webinar: A Comparison of Two Liquid Biopsy Approaches in Advanced Lung Carcinoma More
Webinar: Analytical Utility of Mass-Spec Liquid Biopsy for NSCLC and Melanoma Samples More
Webinar: Applications and Challenges of Using ctDNA as Non-Invasive Tumor Markers More
Video: Liquid Biopsy - Clinical Applications & Current Challenges More
Webinar: Liquid Biopsy – Applications of CTCs and ctDNA as a Non-Invasive Tumor Tracker More
Video: Analysis of ctDNA and Cells with UltraSEEK on the MassARRAY System More
Video: Rapid Mutation Profiling of Liquid Biopsy and Solid Tumors More
Interview: How the MassARRAY Enabled Biron to Reliably Test CYP2D6 Copy Number Variation More
Webinar: Evaluating Drug-Drug Interactions – Implications of Phenoconversions More
Hybrid Alleles: Why It’s Important to Detect Them & How Agena Does it Better More
Webinar: A Pharmacogenetic (PGx) Blindspot: The Prevalence and Impact of CYP2D6 Hybrid Alleles More
Webinar: PGx Beyond Drug-Metabolizing Enzymes: A Multigene Approach to Predicting Drug Response More
Webinar: The Prevalence & Impact of CYP2D6 Hybrid Alleles & Copy Number Variation More
Webinar: Authenticating Laboratory Results – Molecular Sample Tracking for NGS Laboratories More
Webinar: Detection of Therapeutically Targetable Mutations in NSCLC More
Webinar: The Promise of Liquid Biopsy for Individualizing Cancer Care More
Webinar: A Comparison of cfDNA Approaches to Guide Targeted Therapy in NSCLC More
Webinar: Responding to the COVID-19 Pandemic - Clinical Laboratories Perspectives More
Webinar: Going beyond EGFR - Evaluating Technologies for Molecular Genetic Testing in NSCLC More
Webinar: Evaluating Drug-Drug Interactions – Implications of Phenoconversions More
Webinar: A Pharmacogenetic (PGx) Blindspot: The Prevalence and Impact of CYP2D6 Hybrid Alleles More
Webinar: Targeted Detection of MET and NTRK Oncogenic Variants in Routine Molecular Analysis More
Webinar: PGx Beyond Drug-Metabolizing Enzymes: A Multigene Approach to Predicting Drug Response More
Webinar: Validating a Diagnostic Mass Spec Platform for a Molecular Pathology Service Lab More
Webinar: A Comparison of Two Liquid Biopsy Approaches in Advanced Lung Carcinoma More
Webinar: Analytical Utility of Mass-Spec Liquid Biopsy for NSCLC and Melanoma Samples More
Webinar: The Prevalence & Impact of CYP2D6 Hybrid Alleles & Copy Number Variation More
Webinar: Applications and Challenges of Using ctDNA as Non-Invasive Tumor Markers More
Webinar: Liquid Biopsy – Applications of CTCs and ctDNA as a Non-Invasive Tumor Tracker More